Overview
Tatjana Pandzic practices practicing medicine in Uppsala, Sweden.
Ms. Pandzic is highly rated in 5 conditions, according to our data. Her clinical expertise encompasses Leukemia, Chronic Lymphocytic Leukemia (CLL), Chronic B-Cell Leukemia (CBCL), and Acute Myeloblastic Leukemia with Maturation.
She is actively involved in clinical research, co-authoring 29 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Tatjana Pandzic
Is Tatjana Pandzic a top-rated expert for Leukemia?
MediFind is an objective health platform that identifies experts based on real-world data. Tatjana Pandzic is classified as an Advanced expert for Leukemia, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Tatjana Pandzic participate in research or clinical trials?
Yes. Tatjana Pandzic has published 29 articles and abstracts on conditions like Leukemia. You can view a list of Tatjana Pandzic's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Acute Myeloblastic Leukemia with Maturation
- Acute Myeloblastic Leukemia without Maturation
- Chronic B-Cell Leukemia (CBCL)Ms. Pandzic isAdvanced. Learn about Chronic B-Cell Leukemia (CBCL).
- Chronic Lymphocytic Leukemia (CLL)Ms. Pandzic isAdvanced. Learn about Chronic Lymphocytic Leukemia (CLL).
- LeukemiaMs. Pandzic isAdvanced. Learn about Leukemia.
- Experienced
- Acute Myeloid Leukemia (AML)Ms. Pandzic isExperienced. Learn about Acute Myeloid Leukemia (AML).
- Angioimmunoblastic T-cell LymphomaMs. Pandzic isExperienced. Learn about Angioimmunoblastic T-cell Lymphoma.
- B-Cell LymphomaMs. Pandzic isExperienced. Learn about B-Cell Lymphoma.
- Lymphofollicular HyperplasiaMs. Pandzic isExperienced. Learn about Lymphofollicular Hyperplasia.
- Myelodysplastic Syndrome (MDS)Ms. Pandzic isExperienced. Learn about Myelodysplastic Syndrome (MDS).
- Non-Hodgkin LymphomaMs. Pandzic isExperienced. Learn about Non-Hodgkin Lymphoma.
- RUNX1 Familial Platelet DisorderMs. Pandzic isExperienced. Learn about RUNX1 Familial Platelet Disorder.
- Small Lymphocytic Lymphoma (SLL)Ms. Pandzic isExperienced. Learn about Small Lymphocytic Lymphoma (SLL).